Displaying 1 to 13 of 13 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Arete Therapeutics Inc A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. |
United States | N/A |
||
|
Cambrios Technologies Corp Developer of proprietary nanostructured electronic materials for the display industry |
United States | 1 Nov 2009 | Series D Initial investment. Round participant. Active |
|
|
Constellation Pharmaceuticals Inc Rapidly Advancing Emerging Epigenetics Research to Develop Novel Oncology Therapeutics |
United States | 1 Jun 2010 | Series B Follow-on investment. Round participant. Active |
|
|
|
Constellation Pharmaceuticals Inc Rapidly Advancing Emerging Epigenetics Research to Develop Novel Oncology Therapeutics |
United States | Series A Initial investment. Round participant. Active |
||
|
|
Ikaria Inc Developer of innovative therapeutics and interventions to meet the significant needs of critically ill patients |
United States | N/A |
||
|
|
KYTHERA Biopharmaceuticals Inc |
United States | 1 Sep 2011 | Series D |
|
|
|
KYTHERA Biopharmaceuticals Inc |
United States | 1 Jul 2006 | Series B Active |
|
|
|
KYTHERA Biopharmaceuticals Inc |
United States | 1 May 2008 | Series C |
|
|
|
Limerick BioPharma Inc |
United States | 1 Jul 2009 | Series C Active |
|
|
|
Limerick BioPharma Inc |
United States | 1 Jun 2008 | Venture Active |
|
|
Siluria Technologies Inc Maker of nanotechnology-enabled products for cleantech-related markets |
United States | 1 Jul 2012 | Series C Active |
|
|
|
Siluria Technologies Inc Maker of nanotechnology-enabled products for cleantech-related markets |
United States | 19 Oct 2010 | Series A Active |
|
|
|
Siluria Technologies Inc Maker of nanotechnology-enabled products for cleantech-related markets |
United States | 1 Sep 2011 | Series B Active |